PPH icon

VanEck Pharmaceutical ETF
PPH

Overview Fund Activity

50 hedge funds and large institutions have $56.5M invested in VanEck Pharmaceutical ETF in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-4
Holders Change %
-7.41%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
16
Reduced
9
Closed
6
Calls
$866K
Puts
$2.07M
Net Calls
-$1.2M
Net Calls Change
-$887K

Top Buyers

1
CCP
1
Clough Capital Partners
Massachusetts
$6.78M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$5.01M
3
Vontobel Holding
3
Vontobel Holding
Switzerland
$728K
4
Morgan Stanley
4
Morgan Stanley
New York
$4.36M
5
UBS Group
5
UBS Group
Switzerland
$548K

Top Sellers

1
Bank of America
1
Bank of America
North Carolina
$9.11M
2
Osaic Holdings
2
Osaic Holdings
Arizona
$638K
3
Citadel Advisors
3
Citadel Advisors
Florida
$3.56M
4
TRCT
4
Tower Research Capital (TRC)
New York
$1.3M
5
RJA
5
Raymond James & Associates
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
51
Qube Research & Technologies (QRT)
United Kingdom
– -$240K -3,280 Closed
ASN
52
Advisory Services Network
Georgia
– -$120K -1,636 Closed
PSIWM
53
Paradigm Strategies in Wealth Management
Minnesota
– -$60K -818 Closed
APA
54
American Portfolios Advisors
New York
– -$2.41K -33 Closed
1 2
3